Clinical trials: Oral Melatonin
Breast Cancer
Melatonin Versus Placebo in Breast Cancer
The purpose of this research study is to determine whether melatonin taken every night can affect blood levels of estrogen or IGF (insulin-growth factor levels).
- Trial name
- NCT01805089
- Testing
- Melatonin 3 mg
- Where
- 2 sites in United States
- Volunteers
- 95 people
- Sponsor
- Dana-Farber Cancer Institute
Oral Squamous Cell Carcinoma, Neoadjuvant Chemotherapy
Melatonin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response in Locally Advanced Oral Squamous Cell Carcinoma
Backgrounds Squamous cell carcinoma of the oral cancer (OSCC) is the sixth most common malignancy. Surgery is the mainstay of treatment for oral cancers.
- Trial name
- NCT04137627
- Testing
- Melatonin 20 MG Oral Capsule
- Where
- Indonesia
- Volunteers
- 50 people
- Sponsor
- Universitas Indonesia